Prognostic Value of Matrix Metalloproteinase 9 (MMP9) in Patients Following Off-Pump Coronary Artery Bypass Grafting

Background: Matrix metalloproteinase 9 (MMP9) has recently emerged as a risk predictor in patients with cardiovascular diseases (CVD). However, little is known regarding the significance of elevated plasma MMP9 levels in patients during the long-term period following myocardial revascularisation. We...

Full description

Saved in:
Bibliographic Details
Main Authors: Mikhail Popov, Siarhei Dabravolski, Vladislav Dontsov, Sergei Vzvarov, Evgeniy Agafonov, Dmitriy Zybin, Olga Radchenkova, Dmitriy Saveliev, Victoria Pronina, Natalia Kashirina, Liudmila Lipatova, Mikhail Peklo, Pavel Rutkevich, Elena Yanushevskaya, Alisa Sokolovskaya, Arkadiy Metelkin, Svetlana Verkhova, Nikita Nikiforov, Dmitriy Shumakov
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/15/6/908
Tags: Add Tag
No Tags, Be the first to tag this record!